Press release
RSV Diagnostics Market Trend | Industry Analysis Report, 2019
Human respiratory syncytial virus (RSV) is a virus that commonly causes lower respiratory tract infection. Human respiratory syncytial virus infections are acquired during hospital visits. Infants and in young children are more prone to human respiratory syncytial virus (RSV) infection. RSV infections affect lungs and respiratory tract of an individual. In premature babies and children with previous presence of diseases, RSV infections affect heart and immune systems as well resulting in serious illness. Common symptoms of RSV infection include, cold, cough, headache and weakness. Human RSV infection is highly contagious and its mode of transfer is through liquid droplets produced during coughing and sneezing.All the RSV diagnostics tests currently available in the market use sputum and saliva as specimen for detection of RSV infection. Based on the tests used to detect RSV infection, this market is segmented into Immunofluorescence, Rapid antigen detection test, Cell culture test, Reverse transcriptase polymerase chain reaction (RT-PCR) kits, Serological tests, Others.
Request to View Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2080
Many clinics perform antigen detection test for diagnosis of human respiratory syncytial virus infection. In most of the cases, results of antigen detection tests are validated by cell culture tests. Antigen detection testsare 80% to 90% more sensitive than cell culture test for detection of RSV infection. Currently, reverse transcriptase polymerase chain reaction (RT-PCR) kits are also available in the market for the detection of human respiratory syncytial virus. Though serological tests are available in the market, they are less frequently used for routine diagnosis. Furthermore,based on the type of end users, The RSV Diagnosis Market is segmented as follows: Hospitals, Physicians’ offices, Commercial labs, Private Labs.
Some of the major companies contributing to global RSV diagnostics market are Becton, Dickinson and Company, Abbott Laboratories, Alere, Inc., Quidel Corporation, and Focus Diagnostics, Inc.
View Report -
https://www.transparencymarketresearch.com/rsv-diagnostics-market.html
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release RSV Diagnostics Market Trend | Industry Analysis Report, 2019 here
News-ID: 963497 • Views: …
More Releases from Transparency Market Research
Merchandising Units Market Set to Reach USD 846.3 Mn by 2032, Driven by Technolo …
The global Merchandising Units Market is witnessing a phase of sustained growth as retail formats evolve and consumer engagement strategies become increasingly data-driven. Merchandising units comprising shelves, racks, stands, and customized display systems play a critical role in enhancing product visibility, optimizing retail space, and improving in-store experiences. According to the latest industry outlook, the global merchandising units market was valued at US$ 504.4 Mn in 2023 and is projected…
Meningitis Treatment Market to Reach US$ 234.8 Million by 2034, Expanding at 4.1 …
The global meningitis treatment market represents a critical segment of the pharmaceutical and healthcare industry, driven by the urgent medical need to manage and treat life-threatening infections of the protective membranes covering the brain and spinal cord. Meningitis can be caused by bacterial, viral, fungal, or parasitic infections, with bacterial meningitis being the most severe and requiring immediate medical intervention. The market encompasses a wide range of therapeutics, including antibiotics,…
Metabolism Assays Market Set for Steady Growth at 6.7% CAGR Through 2034 - By Pr …
The global metabolism assays market was valued at US$ 1.5 Bn in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 6.7% from 2024 to 2034, reaching more than US$ 3.1 Bn by the end of 2034. This sustained growth trajectory reflects the increasing importance of metabolic profiling across pharmaceutical research, clinical diagnostics, and academic research environments.
Preview crucial insights and findings from our Report in…
Metagenomics Market Outlook 2031: Expanding from US$ 1.6 Billion to US$ 4.6 Bill …
The global metagenomics market is emerging as a critical pillar of modern biological research, diagnostics, and environmental science. Valued at US$ 1.6 billion in 2022, the market is projected to reach US$ 4.6 billion by the end of 2031, advancing at a strong compound annual growth rate (CAGR) of 12.9% from 2023 to 2031. This rapid expansion reflects growing demand for culture-independent methods that enable comprehensive analysis of microbial communities…
More Releases for RSV
The Rise In The Prevalence Of RSV Infection : A Key Catalyst Accelerating Global …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Respiratory Syncytial Virus (RSV) Therapeutics Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market encompassing therapeutics for respiratory syncytial virus (rsv) has witnessed substantial, rapid expansion lately, projected to increase its valuation from $1.6 billion in 2024 to $2 billion just one year later…
The Rise In The Prevalence Of RSV Infection : Transformative Forces Shaping the …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Respiratory Syncytial Virus (RSV) Therapeutics Industry Market Size Be by 2025?
The market size for therapeutics treating the respiratory syncytial virus (RSV) has seen significant expansion in the past few years. It is expected to surge from $1.6 billion in 2024 to $2 billion in 2025,…
RSV Vaccine Market To Reach 731 million by 2040, Due To Increasing Awareness on …
According to our latest market report "RSV Vaccine Market, Till 2040 by Type of Vaccine, Route of Administration, Target Patient Population, Distribution Channel, Key Geographical Regions and Leading Players", the RSV Vaccine market size is projected to reach USD 731 million by 2040 from USD 1,149 million in current year, during the forecast period.
To request quote of this report, please visit:
https://www.rootsanalysis.com/reports/rsv-vaccine-market/request-quote.html
In the dynamic landscape of preventive therapies for respiratory…
Global RSV Diagnostic Products Market Size & Trends
According to a new market research report published by Global Market Estimates, the global RSV diagnostic products market is expected to grow at a CAGR of 11.4% from 2023 to 2028.
Ongoing advancements in diagnostic technologies, specifically PCR and rapid point-of-care testing, play a crucial role. These advancements offer heightened accuracy, faster results, and increased accessibility, enabling prompt and precise identification of RSV infections.
Browse 147 Market Data Tables and 115 Figures…
Respiratory Syncytial Virus (RSV) Therapeutics Market Size to Reach USD 9080.84 …
Respiratory Syncytial Virus (RSV) Therapeutics Market Scope & Overview
Respiratory Syncytial Virus (RSV) Therapeutics Market size was USD 1040.65 Million in 2022 and is expected to Reach USD 9080.84 Million by 2030 and grow at a CAGR of 31.1% over the forecast period of 2023-2030.
The Respiratory Syncytial Virus (RSV) Therapeutics market is a vibrant, fiercely competitive sector that is essential to digital marketing. The demand for effective has increased as companies…
Respiratory Syncytial Virus (RSV) Therapeutics Market - Conquering RSV: Advancin …
Newark, New Castle, USA: The "Respiratory Syncytial Virus (RSV) Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Respiratory Syncytial Virus (RSV) Therapeutics Market: https://www.growthplusreports.com/report/respiratory-syncytial-virus-rsv-therapeutics-market/8519
This latest report…
